Stifel Financial’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.37M | Buy |
7,300
+452
| +7% | +$87.1K | ﹤0.01% | 2227 |
|
|
2025
Q4 | $1.3M | Buy |
6,848
+219
| +3% | +$40.5K | ﹤0.01% | 2266 |
|
|
2025
Q3 | $1.1M | Sell |
6,629
-127
| -2% | -$20.7K | ﹤0.01% | 2343 |
|
|
2025
Q2 | $1.04M | Sell |
6,756
-50
| -0.7% | -$7.45K | ﹤0.01% | 2308 |
|
|
2025
Q1 | $1.07M | Buy |
6,806
+80
| +1% | +$13K | ﹤0.01% | 2174 |
|
|
2024
Q4 | $1.06M | Sell |
6,726
-6
| -0.1% | -$1.01K | ﹤0.01% | 2210 |
|
|
2024
Q3 | $1.19M | Sell |
6,732
-57
| -0.8% | -$10.1K | ﹤0.01% | 2112 |
|
|
2024
Q2 | $1.14M | Sell |
6,789
-339
| -5% | -$55.4K | ﹤0.01% | 2085 |
|
|
2024
Q1 | $1.19M | Hold |
7,128
| – | – | ﹤0.01% | 2078 |
|
|
2023
Q4 | $1.18M | Sell |
7,128
-151
| -2% | -$23.2K | ﹤0.01% | 2036 |
|
|
2023
Q3 | $1.13M | Sell |
7,279
-100
| -1% | -$16K | ﹤0.01% | 1971 |
|
|
2023
Q2 | $1.15M | Hold |
7,379
| – | – | ﹤0.01% | 1996 |
|
|
2023
Q1 | $1.2M | Sell |
7,379
-5,529
| -43% | -$895K | ﹤0.01% | 1930 |
|
|
2022
Q4 | $2.06M | Buy |
12,908
+6,720
| +109% | +$1.06M | ﹤0.01% | 1506 |
|
|
2022
Q3 | $872K | Sell |
6,188
-690
| -10% | -$104K | ﹤0.01% | 2064 |
|
|
2022
Q2 | $1M | Sell |
6,878
-605
| -8% | -$90.1K | ﹤0.01% | 1994 |
|
|
2022
Q1 | $1.21M | Buy |
7,483
+695
| +10% | +$113K | ﹤0.01% | 1971 |
|
|
2021
Q4 | $1.28M | Sell |
6,788
-12,914
| -66% | -$2.49M | ﹤0.01% | 1935 |
|
|
2021
Q3 | $3.98M | Sell |
19,702
-1,119
| -5% | -$235K | 0.01% | 1145 |
|
|
2021
Q2 | $4.2M | Buy |
20,821
+412
| +2% | +$76.7K | 0.01% | 1117 |
|
|
2021
Q1 | $3.58M | Buy |
20,409
+839
| +4% | +$152K | 0.01% | 1155 |
|
|
2020
Q4 | $3.32M | Buy |
19,570
+750
| +4% | +$124K | 0.01% | 1084 |
|
|
2020
Q3 | $3.05M | Buy |
18,820
+559
| +3% | +$90.9K | 0.01% | 997 |
|
|
2020
Q2 | $2.98M | Buy |
18,261
+10,536
| +136% | +$1.6M | 0.01% | 951 |
|
|
2020
Q1 | $988K | Buy |
7,725
+25
| +0.3% | +$3.37K | ﹤0.01% | 1447 |
|
|
2019
Q4 | $1.07M | Buy |
7,700
+810
| +12% | +$106K | ﹤0.01% | 1775 |
|
|
2019
Q3 | $813K | Sell |
6,890
-1,220
| -15% | -$152K | ﹤0.01% | 1879 |
|
|
2019
Q2 | $1.04M | Sell |
8,110
-300
| -4% | -$37K | ﹤0.01% | 1774 |
|
|
2019
Q1 | $1.08M | Buy |
8,410
+840
| +11% | +$106K | ﹤0.01% | 1601 |
|
|
2018
Q4 | $836K | Sell |
7,570
-150
| -2% | -$18.1K | ﹤0.01% | 1651 |
|
|
2018
Q3 | $1.05M | Buy |
7,720
+100
| +1% | +$13K | ﹤0.01% | 1631 |
|
|
2018
Q2 | $914K | Sell |
7,620
-6,946
| -48% | -$819K | ﹤0.01% | 1684 |
|
|
2018
Q1 | $1.75M | Sell |
14,566
-700
| -5% | -$87.8K | 0.01% | 1236 |
|
|
2017
Q4 | $1.9M | Sell |
15,266
-29
| -0.2% | -$3.7K | 0.01% | 1171 |
|
|
2017
Q3 | $2.05M | Buy |
15,295
+120
| +0.8% | +$15.6K | 0.01% | 1106 |
|
|
2017
Q2 | $1.91M | Buy |
15,175
+75
| +0.5% | +$9.04K | 0.01% | 1119 |
|
|
2017
Q1 | $1.8M | Buy |
15,100
+337
| +2% | +$39.4K | 0.01% | 1128 |
|
|
2016
Q4 | $1.59M | Buy |
14,763
+9,575
| +185% | +$1.04M | 0.01% | 1127 |
|
|
2016
Q3 | $598K | Sell |
5,188
-1,841
| -26% | -$210K | ﹤0.01% | 1629 |
|
|
2016
Q2 | $721K | Sell |
7,029
-884
| -11% | -$94.3K | ﹤0.01% | 1538 |
|
|
2016
Q1 | $820K | Sell |
7,913
-857
| -10% | -$89.4K | ﹤0.01% | 1327 |
|
|
2015
Q4 | $1.11M | Buy |
8,770
+520
| +6% | +$63.7K | 0.01% | 1246 |
|
|
2015
Q3 | $943K | Buy |
8,250
+450
| +6% | +$59.6K | 0.01% | 1239 |
|
|
2015
Q2 | $1.05M | Buy |
7,800
+800
| +11% | +$106K | 0.01% | 1339 |
|
|
2015
Q1 | $907K | Buy |
7,000
+1,000
| +17% | +$126K | 0.01% | 1327 |
|
|
2014
Q4 | $692K | Buy |
+6,000
| New | +$676K | ﹤0.01% | 1453 |
|
Other funds holding BBH
MIM
CCA
BFG
Stifel Financial's BBH Position: Q1 2026 in Review
Stifel Financial increased its VanEck Biotech ETF (BBH) stake by 6.6% in Q1 2026, buying an estimated $87.1K and bringing the position to 7,300 shares worth $1.37M. The position accounts for ﹤0.01% of the portfolio, ranked #2227.
Stifel Financial first reported a position in BBH in Q4 2014 and has held it in 46 quarters since. The position peaked at $4.2M in Q2 2021. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.
- Stifel Financial held 7,300 shares of VanEck Biotech ETF worth $1.37M as of Q1 2026.
- Stifel Financial bought 452 VanEck Biotech ETF shares in Q1 2026, an estimated $87.1K.
- VanEck Biotech ETF made up ﹤0.01% of Stifel Financial's portfolio in Q1 2026, its #2227 holding.
- Stifel Financial first reported a position in VanEck Biotech ETF in Q4 2014 and has held it in 46 quarters since.
- Stifel Financial's VanEck Biotech ETF position peaked at $4.2M in Q2 2021.
- 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.
Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.